Hepatitis E virus antibodies in patients with chronic liver disease.
In the United States, the seroprevalence rate for hepatitis E virus (HEV) is approximately 20%. This study examined HEV seroprevalence in persons with and without chronic liver disease. Our data indicate that HEV seropositivity is high in patients with chronic liver disease and that HEV seroprevalence increases significantly with age.
Atiq
Muslim
M
University of Cincinnati, Cincinnati, OH 45267, USA.
Shire
Norah J
NJ
Barrett
Anna
A
Rouster
Susan D
SD
Sherman
Kenneth E
KE
Shata
Mohamed T
MT
D000328:Adult; D002908:Chronic Disease; D003430:Cross-Sectional Studies; D005260:Female; D006508:Hepatitis Antibodies / Q000097:blood*; D016751:Hepatitis E / Q000453:epidemiology* / Q000821:virology; D016752:Hepatitis E virus / Q000276:immunology*; D006801:Humans; D008107:Liver Diseases / Q000453:epidemiology* / Q000276:immunology / Q000821:virology; D008297:Male; D008875:Middle Aged; D009820:Ohio / Q000453:epidemiology; D012307:Risk Factors; D016036:Seroepidemiologic Studies
D006508:Hepatitis Antibodies